1 Brucellosis Vaccines Market Overview 1.1 Brucellosis Vaccines Product Overview 1.2 Brucellosis Vaccines Market Segment by Type 1.2.1 S19 Vaccine 1.2.2 RB51 Vaccine Strain 1.2.3 Other 1.3 Global Brucellosis Vaccines Market Size by Type (2015-2026) 1.3.1 Global Brucellosis Vaccines Market Size Overview by Type (2015-2026) 1.3.2 Global Brucellosis Vaccines Historic Market Size Review by Type (2015-2020) 1.3.2.1 Global Brucellosis Vaccines Sales Market Share Breakdown by Type (2015-2026) 1.3.2.2 Global Brucellosis Vaccines Revenue Market Share Breakdown by Type (2015-2026) 1.3.2.3 Global Brucellosis Vaccines Average Selling Price (ASP) by Type (2015-2026) 1.3.3 Global Brucellosis Vaccines Market Size Forecast by Type (2021-2026) 1.3.3.1 Global Brucellosis Vaccines Sales Market Share Breakdown by Application (2021-2026) 1.3.3.2 Global Brucellosis Vaccines Revenue Market Share Breakdown by Application (2021-2026) 1.3.3.3 Global Brucellosis Vaccines Average Selling Price (ASP) by Application (2021-2026) 1.4 Key Regions Market Size Segment by Type (2015-2020) 1.4.1 North America Brucellosis Vaccines Sales Breakdown by Type (2015-2026) 1.4.2 Europe Brucellosis Vaccines Sales Breakdown by Type (2015-2026) 1.4.3 Asia-Pacific Brucellosis Vaccines Sales Breakdown by Type (2015-2026) 1.4.4 Latin America Brucellosis Vaccines Sales Breakdown by Type (2015-2026) 1.4.5 Middle East and Africa Brucellosis Vaccines Sales Breakdown by Type (2015-2026) 2 Global Brucellosis Vaccines Market Competition by Company 2.1 Global Top Players by Brucellosis Vaccines Sales (2015-2020) 2.2 Global Top Players by Brucellosis Vaccines Revenue (2015-2020) 2.3 Global Top Players Brucellosis Vaccines Average Selling Price (ASP) (2015-2020) 2.4 Global Top Manufacturers Brucellosis Vaccines Manufacturing Base Distribution, Sales Area, Product Type 2.5 Brucellosis Vaccines Market Competitive Situation and Trends 2.5.1 Brucellosis Vaccines Market Concentration Rate (2015-2020) 2.5.2 Global 5 and 10 Largest Manufacturers by Brucellosis Vaccines Sales and Revenue in 2019 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brucellosis Vaccines as of 2019) 2.7 Date of Key Manufacturers Enter into Brucellosis Vaccines Market 2.8 Key Manufacturers Brucellosis Vaccines Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Global Brucellosis Vaccines Status and Outlook by Region (2015-2026) 3.1 Global Brucellosis Vaccines Market Size and CAGR by Region: 2015 VS 2020 VS 2026 3.2 Global Brucellosis Vaccines Market Size Market Share by Region (2015-2020) 3.2.1 Global Brucellosis Vaccines Sales Market Share by Region (2015-2020) 3.2.2 Global Brucellosis Vaccines Revenue Market Share by Region (2015-2020) 3.2.3 Global Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2015-2020) 3.3 Global Brucellosis Vaccines Market Size Market Share by Region (2021-2026) 3.3.1 Global Brucellosis Vaccines Sales Market Share by Region (2021-2026) 3.3.2 Global Brucellosis Vaccines Revenue Market Share by Region (2021-2026) 3.3.3 Global Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2021-2026) 3.4 North America Brucellosis Vaccines Market Size YoY Growth (2015-2026) 3.4.1 North America Brucellosis Vaccines Revenue YoY Growth (2015-2026) 3.4.2 North America Brucellosis Vaccines Sales YoY Growth (2015-2026) 3.5 Asia-Pacific Brucellosis Vaccines Market Size YoY Growth (2015-2026) 3.5.1 Asia-Pacific Brucellosis Vaccines Revenue YoY Growth (2015-2026) 3.5.2 Asia-Pacific Brucellosis Vaccines Sales YoY Growth (2015-2026) 3.6 Europe Brucellosis Vaccines Market Size YoY Growth (2015-2026) 3.6.1 Europe Brucellosis Vaccines Revenue YoY Growth (2015-2026) 3.6.2 Europe Brucellosis Vaccines Sales YoY Growth (2015-2026) 3.7 Latin America Brucellosis Vaccines Market Size YoY Growth (2015-2026) 3.7.1 Latin America Brucellosis Vaccines Revenue YoY Growth (2015-2026) 3.7.2 Latin America Brucellosis Vaccines Sales YoY Growth (2015-2026) 3.8 Middle East and Africa Brucellosis Vaccines Market Size YoY Growth (2015-2026) 3.8.1 Middle East and Africa Brucellosis Vaccines Revenue YoY Growth (2015-2026) 3.8.2 Middle East and Africa Brucellosis Vaccines Sales YoY Growth (2015-2026) 4 Global Brucellosis Vaccines by Application 4.1 Brucellosis Vaccines Segment by Application 4.1.1 Cattle 4.1.2 Sheep 4.1.3 Other 4.2 Global Brucellosis Vaccines Sales by Application: 2015 VS 2020 VS 2026 4.3 Global Brucellosis Vaccines Historic Sales by Application (2015-2020) 4.4 Global Brucellosis Vaccines Forecasted Sales by Application (2021-2026) 4.5 Key Regions Brucellosis Vaccines Market Size by Application 4.5.1 North America Brucellosis Vaccines by Application 4.5.2 Europe Brucellosis Vaccines by Application 4.5.3 Asia-Pacific Brucellosis Vaccines by Application 4.5.4 Latin America Brucellosis Vaccines by Application 4.5.5 Middle East and Africa Brucellosis Vaccines by Application 5 North America Brucellosis Vaccines Market Size by Country (2015-2026) 5.1 North America Market Size Market Share by Country (2015-2020) 5.1.1 North America Brucellosis Vaccines Sales Market Share by Country (2015-2020) 5.1.2 North America Brucellosis Vaccines Revenue Market Share by Country (2015-2020) 5.2 North America Market Size Market Share by Country (2021-2026) 5.2.1 North America Brucellosis Vaccines Sales Market Share by Country (2021-2026) 5.2.2 North America Brucellosis Vaccines Revenue Market Share by Country (2021-2026) 5.3 North America Market Size YoY Growth by Country 5.3.1 U.S. Brucellosis Vaccines Market Size YoY Growth (2015-2026) 5.3.2 Canada Brucellosis Vaccines Market Size YoY Growth (2015-2026) 6 Europe Brucellosis Vaccines Market Size by Country (2015-2026) 6.1 Europe Market Size Market Share by Country (2015-2020) 6.1.1 Europe Brucellosis Vaccines Sales Market Share by Country (2015-2020) 6.1.2 Europe Brucellosis Vaccines Revenue Market Share by Country (2015-2020) 6.2 Europe Market Size Market Share by Country (2021-2026) 6.2.1 Europe Brucellosis Vaccines Sales Market Share by Country (2021-2026) 6.2.2 Europe Brucellosis Vaccines Revenue Market Share by Country (2021-2026) 6.3 Europe Market Size YoY Growth by Country 6.3.1 Germany Brucellosis Vaccines Market Size YoY Growth (2015-2026) 6.3.2 France Brucellosis Vaccines Market Size YoY Growth (2015-2026) 6.3.3 U.K. Brucellosis Vaccines Market Size YoY Growth (2015-2026) 6.3.4 Italy Brucellosis Vaccines Market Size YoY Growth (2015-2026) 6.3.5 Russia Brucellosis Vaccines Market Size YoY Growth (2015-2026) 7 Asia-Pacific Brucellosis Vaccines Market Size by Country (2015-2026) 7.1 Asia-Pacific Market Size Market Share by Country (2015-2020) 7.1.1 Asia-Pacific Brucellosis Vaccines Sales Market Share by Country (2015-2020) 7.1.2 Asia-Pacific Brucellosis Vaccines Revenue Market Share by Country (2015-2020) 7.2 Asia-Pacific Market Size Market Share by Country (2021-2026) 7.2.1 Asia-Pacific Brucellosis Vaccines Sales Market Share by Country (2021-2026) 7.2.2 Asia-Pacific Brucellosis Vaccines Revenue Market Share by Country (2021-2026) 7.3 Asia-Pacific Market Size YoY Growth by Country 7.3.1 China Brucellosis Vaccines Market Size YoY Growth (2015-2026) 7.3.2 Japan Brucellosis Vaccines Market Size YoY Growth (2015-2026) 7.3.3 South Korea Brucellosis Vaccines Market Size YoY Growth (2015-2026) 7.3.4 India Brucellosis Vaccines Market Size YoY Growth (2015-2026) 7.3.5 Australia Brucellosis Vaccines Market Size YoY Growth (2015-2026) 7.3.6 Taiwan Brucellosis Vaccines Market Size YoY Growth (2015-2026) 7.3.7 Indonesia Brucellosis Vaccines Market Size YoY Growth (2015-2026) 7.3.8 Thailand Brucellosis Vaccines Market Size YoY Growth (2015-2026) 7.3.9 Malaysia Brucellosis Vaccines Market Size YoY Growth (2015-2026) 7.3.10 Philippines Brucellosis Vaccines Market Size YoY Growth (2015-2026) 7.3.11 Vietnam Brucellosis Vaccines Market Size YoY Growth (2015-2026) 8 Latin America Brucellosis Vaccines Market Size by Country (2015-2026) 8.1 Latin America Market Size Market Share by Country (2015-2020) 8.1.1 Latin America Brucellosis Vaccines Sales Market Share by Country (2015-2020) 8.1.2 Latin America Brucellosis Vaccines Revenue Market Share by Country (2015-2020) 8.2 Latin America Market Size Market Share by Country (2021-2026) 8.2.1 Latin America Brucellosis Vaccines Sales Market Share by Country (2021-2026) 8.2.2 Latin America Brucellosis Vaccines Revenue Market Share by Country (2021-2026) 8.3 Latin America Market Size YoY Growth by Country 8.3.1 Mexico Brucellosis Vaccines Market Size YoY Growth (2015-2026) 8.3.2 Brazil Brucellosis Vaccines Market Size YoY Growth (2015-2026) 8.3.3 Argentina Brucellosis Vaccines Market Size YoY Growth (2015-2026) 9 Middle East and Africa Brucellosis Vaccines Market Size by Country (2015-2026) 9.1 Middle East and Africa Market Size Market Share by Country (2015-2020) 9.1.1 Middle East and Africa Brucellosis Vaccines Sales Market Share by Country (2015-2020) 9.1.2 Middle East and Africa Brucellosis Vaccines Revenue Market Share by Country (2015-2020) 9.2 Middle East and Africa Market Size Market Share by Country (2021-2026) 9.2.1 Middle East and Africa Brucellosis Vaccines Sales Market Share by Country (2021-2026) 9.2.2 Middle East and Africa Brucellosis Vaccines Revenue Market Share by Country (2021-2026) 9.3 Middle East and Africa Market Size YoY Growth by Country 9.3.1 Turkey Brucellosis Vaccines Market Size YoY Growth (2015-2026) 9.3.2 Saudi Arabia Brucellosis Vaccines Market Size YoY Growth (2015-2026) 9.3.3 U.A.E Brucellosis Vaccines Market Size YoY Growth (2015-2026) 10 Company Profiles and Key Figures in Brucellosis Vaccines Business 10.1 Jinyu 10.1.1 Jinyu Corporation Information 10.1.2 Jinyu Description, Business Overview and Total Revenue 10.1.3 Jinyu Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020) 10.1.4 Jinyu Brucellosis Vaccines Products Offered 10.1.5 Jinyu Recent Development 10.2 Colorado Serum 10.2.1 Colorado Serum Corporation Information 10.2.2 Colorado Serum Description, Business Overview and Total Revenue 10.2.3 Colorado Serum Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020) 10.2.4 Jinyu Brucellosis Vaccines Products Offered 10.2.5 Colorado Serum Recent Development 10.3 Boehringer Ingelheim 10.3.1 Boehringer Ingelheim Corporation Information 10.3.2 Boehringer Ingelheim Description, Business Overview and Total Revenue 10.3.3 Boehringer Ingelheim Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020) 10.3.4 Boehringer Ingelheim Brucellosis Vaccines Products Offered 10.3.5 Boehringer Ingelheim Recent Development 10.4 Biogenesis-Bago 10.4.1 Biogenesis-Bago Corporation Information 10.4.2 Biogenesis-Bago Description, Business Overview and Total Revenue 10.4.3 Biogenesis-Bago Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020) 10.4.4 Biogenesis-Bago Brucellosis Vaccines Products Offered 10.4.5 Biogenesis-Bago Recent Development 10.5 Vetal Company 10.5.1 Vetal Company Corporation Information 10.5.2 Vetal Company Description, Business Overview and Total Revenue 10.5.3 Vetal Company Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020) 10.5.4 Vetal Company Brucellosis Vaccines Products Offered 10.5.5 Vetal Company Recent Development 10.6 CZ Veterinaria 10.6.1 CZ Veterinaria Corporation Information 10.6.2 CZ Veterinaria Description, Business Overview and Total Revenue 10.6.3 CZ Veterinaria Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020) 10.6.4 CZ Veterinaria Brucellosis Vaccines Products Offered 10.6.5 CZ Veterinaria Recent Development 10.7 SYVA Laboratorios 10.7.1 SYVA Laboratorios Corporation Information 10.7.2 SYVA Laboratorios Description, Business Overview and Total Revenue 10.7.3 SYVA Laboratorios Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020) 10.7.4 SYVA Laboratorios Brucellosis Vaccines Products Offered 10.7.5 SYVA Laboratorios Recent Development 10.8 Indian Immunologicals 10.8.1 Indian Immunologicals Corporation Information 10.8.2 Indian Immunologicals Description, Business Overview and Total Revenue 10.8.3 Indian Immunologicals Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020) 10.8.4 Indian Immunologicals Brucellosis Vaccines Products Offered 10.8.5 Indian Immunologicals Recent Development 10.9 Qilu 10.9.1 Qilu Corporation Information 10.9.2 Qilu Description, Business Overview and Total Revenue 10.9.3 Qilu Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020) 10.9.4 Qilu Brucellosis Vaccines Products Offered 10.9.5 Qilu Recent Development 10.10 Tecnovax 10.10.1 Company Basic Information, Manufacturing Base and Competitors 10.10.2 Brucellosis Vaccines Product Category, Application and Specification 10.10.3 Tecnovax Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2015-2020) 10.10.4 Main Business Overview 10.10.5 Tecnovax Recent Development 10.11 Hester Biosciences 10.11.1 Hester Biosciences Corporation Information 10.11.2 Hester Biosciences Description, Business Overview and Total Revenue 10.11.3 Hester Biosciences Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020) 10.11.4 Hester Biosciences Brucellosis Vaccines Products Offered 10.11.5 Hester Biosciences Recent Development 10.12 Zoetis 10.12.1 Zoetis Corporation Information 10.12.2 Zoetis Description, Business Overview and Total Revenue 10.12.3 Zoetis Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020) 10.12.4 Zoetis Brucellosis Vaccines Products Offered 10.12.5 Zoetis Recent Development 10.13 Onderstepoort Biological 10.13.1 Onderstepoort Biological Corporation Information 10.13.2 Onderstepoort Biological Description, Business Overview and Total Revenue 10.13.3 Onderstepoort Biological Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020) 10.13.4 Onderstepoort Biological Brucellosis Vaccines Products Offered 10.13.5 Onderstepoort Biological Recent Development 10.14 Instituto Rosenbusch 10.14.1 Instituto Rosenbusch Corporation Information 10.14.2 Instituto Rosenbusch Description, Business Overview and Total Revenue 10.14.3 Instituto Rosenbusch Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020) 10.14.4 Instituto Rosenbusch Brucellosis Vaccines Products Offered 10.14.5 Instituto Rosenbusch Recent Development 10.15 Ceva Sante Animale 10.15.1 Ceva Sante Animale Corporation Information 10.15.2 Ceva Sante Animale Description, Business Overview and Total Revenue 10.15.3 Ceva Sante Animale Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020) 10.15.4 Ceva Sante Animale Brucellosis Vaccines Products Offered 10.15.5 Ceva Sante Animale Recent Development 10.16 Calier & Biologicos Laverlam 10.16.1 Calier & Biologicos Laverlam Corporation Information 10.16.2 Calier & Biologicos Laverlam Description, Business Overview and Total Revenue 10.16.3 Calier & Biologicos Laverlam Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020) 10.16.4 Calier & Biologicos Laverlam Brucellosis Vaccines Products Offered 10.16.5 Calier & Biologicos Laverlam Recent Development 10.17 Biovet 10.17.1 Biovet Corporation Information 10.17.2 Biovet Description, Business Overview and Total Revenue 10.17.3 Biovet Brucellosis Vaccines Sales, Revenue and Gross Margin (2015-2020) 10.17.4 Biovet Brucellosis Vaccines Products Offered 10.17.5 Biovet Recent Development 11 Brucellosis Vaccines Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Brucellosis Vaccines Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Brucellosis Vaccines Industrial Chain Analysis 11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Porter’s Five Forces Analysis 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Distributors 12.3 Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology/Research Approach 14.1.1 Research Programs/Design 14.1.2 Market Size Estimation 14.1.3 Market Breakdown and Data Triangulation 14.2 Data Source 14.2.1 Secondary Sources 14.2.2 Primary Sources 14.3 Author Details 14.4 Disclaimer

List of Tables Table 1. Major Players of S19 Vaccine Table 2. Major Players of RB51 Vaccine Strain Table 3. Major Players of Other Table 4. Global Brucellosis Vaccines Market Size Growth Potential by Type: CAGR (2020-2026) (US$ Million) Table 5. Global Brucellosis Vaccines Sales (M Doses) by Type (2015-2020) (M Doses) Table 6. Global Brucellosis Vaccines Sales Share by Type (2015-2020) Table 7. Global Brucellosis Vaccines Revenue (Million USD) by Type (2015-2020) Table 8. Global Brucellosis Vaccines Revenue Share by Type (2015-2020) Table 9. Global Brucellosis Vaccines Average Selling Price (ASP) (USD/K Doses) by Type (2015-2020) Table 10. Global Brucellosis Vaccines Sales by Type (2021-2026) (M Doses) Table 11. Global Brucellosis Vaccines Sales Share by Type (2021-2026) Table 12. Global Brucellosis Vaccines Revenue (US$ Million) by Type (2021-2026) Table 13. Global Brucellosis Vaccines Revenue Share by Type (2021-2026) Table 14. Global Brucellosis Vaccines Average Selling Price (ASP) (USD/K Doses) by Type (2021-2026) Table 15. North America Brucellosis Vaccines Sales (USD/K Doses) by Type (2015-2020) Table 16. Europe Brucellosis Vaccines Sales (USD/K Doses) by Type (2015-2020) Table 17. Asia-Pacific Brucellosis Vaccines Sales (USD/K Doses) by Type (2015-2020) Table 18. Latin America Brucellosis Vaccines Sales (USD/K Doses) by Type (2015-2020) Table 19. Middle East and Africa Brucellosis Vaccines Sales (USD/K Doses) by Type (2015-2020) Table 20. Global Brucellosis Vaccines Sales (M Doses) by Company (2015-2020) Table 21. Global Brucellosis Vaccines Sales Share by Company (2015-2020) Table 22. Global Brucellosis Vaccines Revenue (Million US$) by Company (2015-2020) Table 23. Global Brucellosis Vaccines Revenue Share by Company (2015-2020) Table 24. Global Market Brucellosis Vaccines Average Selling Price (USD/K Doses) by Company (2015-2020) Table 25. Global Brucellosis Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area Table 26. Global Brucellosis Vaccines Top Manufacturers Product Category Table 27. Global Brucellosis Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) Table 28. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Brucellosis Vaccines as of 2019 Table 29. Date of Key Manufacturers Enter into Brucellosis Vaccines Market Table 30. Key Manufacturers Brucellosis Vaccines Product Type Table 31. Mergers & Acquisitions, Expansion Plans Table 32. Global Brucellosis Vaccines Market Size Comparison by Region (2015-2026) (US$ Million): 2015 VS 2020 VS 2026 Table 33. Global Brucellosis Vaccines Sales (M Doses) by Region (2015-2020) Table 34. Global Brucellosis Vaccines Sales Market Share by Region (2015-2020) Table 35. Global Brucellosis Vaccines Revenue (US$ Million) by Region (2015-2020) Table 36. Global Brucellosis Vaccines Revenue Market Share by Region (2015-2020) Table 37. Global Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2015-2020) Table 38. Global Brucellosis Vaccines Sales (M Doses) by Region (2021-2026) Table 39. Global Brucellosis Vaccines Sales Market Share by Region (2021-2026) Table 40. Global Brucellosis Vaccines Revenue (US$ Million) by Region (2021-2026) Table 41. Global Brucellosis Vaccines Revenue Market Share by Region (2021-2026) Table 42. Global Brucellosis Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 43. Global Brucellosis Vaccines Sales (M Doses) by Application: 2015 VS 2020 VS 2026 Table 44. Global Brucellosis Vaccines Sales (M Doses) by Application (2015-2020) Table 45. Global Brucellosis Vaccines Sales Share by Application (2015-2020) Table 46. Global Brucellosis Vaccines Sales (M Doses) by Application (2021-2026) Table 47. Global Brucellosis Vaccines Sales Share by Application (2021-2026) Table 48. North America Brucellosis Vaccines Sales (M Doses) by Application (2015-2020) Table 49. North America Sales Brucellosis Vaccines Market Share by Application (2015-2020) Table 50. Europe Brucellosis Vaccines Sales (M Doses) by Application (2015-2020) Table 51. Europe Sales Brucellosis Vaccines Market Share by Application In 2019 Table 52. Asia-Pacific Brucellosis Vaccines Sales (M Doses) by Application (2015-2020) Table 53. Asia-Pacific Sales Brucellosis Vaccines Market Share by Application In 2019 Table 54. Latin America Brucellosis Vaccines Sales (M Doses) by Application (2015-2020) Table 55. Latin America Sales Brucellosis Vaccines Market Share by Application In 2019 Table 56. Middle East and Africa Brucellosis Vaccines Sales (M Doses) by Application (2015-2020) Table 57. Middle East and Africa Brucellosis Vaccines Sales Share by Application (2015-2020) Table 58. North America Brucellosis Vaccines Sales (M Doses) by Country (2015-2020) Table 59. North America Brucellosis Vaccines Sales Market Share by Country (2015-2020) Table 60. North America Brucellosis Vaccines Revenue (US$ Million) by Country (2015-2020) Table 61. North America Brucellosis Vaccines Revenue Market Share by Country (2015-2020) Table 62. North America Brucellosis Vaccines Sales (M Doses) by Country (2021-2026) Table 63. North America Brucellosis Vaccines Sales Market Share by Country (2021-2026) Table 64. North America Brucellosis Vaccines Revenue (US$ Million) by Country (2021-2026) Table 65. North America Brucellosis Vaccines Revenue Market Share by Country (2021-2026) Table 66. Europe Brucellosis Vaccines Sales (M Doses) by Country (2015-2020) Table 67. Europe Brucellosis Vaccines Sales Market Share by Country (2015-2020) Table 68. Europe Brucellosis Vaccines Revenue (US$ Million) by Country (2015-2020) Table 69. Europe Brucellosis Vaccines Revenue Market Share by Country (2015-2020) Table 70. Europe Brucellosis Vaccines Sales (M Doses) by Country (2021-2026) Table 71. Europe Brucellosis Vaccines Sales Market Share by Country (2021-2026) Table 72. Europe Brucellosis Vaccines Revenue (US$ Million) by Country (2021-2026) Table 73. Europe Brucellosis Vaccines Revenue Market Share by Country (2021-2026) Table 74. Asia-Pacific Brucellosis Vaccines Sales (M Doses) by Region (2015-2020) Table 75. Asia-Pacific Brucellosis Vaccines Sales Market Share by Region (2015-2020) Table 76. Asia-Pacific Brucellosis Vaccines Revenue (US$ Million) by Region (2015-2020) Table 77. Asia-Pacific Brucellosis Vaccines Revenue Market Share by Region (2015-2020) Table 78. Asia-Pacific Brucellosis Vaccines Sales (M Doses) by Region (2021-2026) Table 79. Asia-Pacific Brucellosis Vaccines Sales Market Share by Region (2021-2026) Table 80. Asia-Pacific Brucellosis Vaccines Revenue (US$ Million) by Region (2021-2026) Table 81. Asia-Pacific Brucellosis Vaccines Revenue Market Share by Region (2021-2026) Table 82. Latin America Brucellosis Vaccines Sales (M Doses) by Country (2015-2020) Table 83. Latin America Brucellosis Vaccines Sales Market Share by Country (2015-2020) Table 84. Latin America Brucellosis Vaccines Revenue (US$ Million) by Country (2015-2020) Table 85. Latin America Brucellosis Vaccines Revenue Market Share by Country (2015-2020) Table 86. Latin America Brucellosis Vaccines Sales (M Doses) by Country (2021-2026) Table 87. Latin America Brucellosis Vaccines Sales Market Share by Country (2021-2026) Table 88. Latin America Brucellosis Vaccines Revenue (US$ Million) by Country (2021-2026) Table 89. Latin America Brucellosis Vaccines Revenue Market Share by Country (2021-2026) Table 90. Middle East and Africa Brucellosis Vaccines Sales (M Doses) by Country (2015-2020) Table 91. Middle East and Africa Brucellosis Vaccines Sales Market Share by Country (2015-2020) Table 92. Middle East and Africa Brucellosis Vaccines Revenue (US$ Million) by Country (2015-2020) Table 93. Middle East and Africa Brucellosis Vaccines Revenue Market Share by Country (2015-2020) Table 94. Middle East and Africa Brucellosis Vaccines Sales (M Doses) by Country (2021-2026) Table 95. Middle East and Africa Brucellosis Vaccines Sales Market Share by Country (2021-2026) Table 96. Middle East and Africa Brucellosis Vaccines Revenue (US$ Million) by Country (2021-2026) Table 97. Middle East and Africa Brucellosis Vaccines Revenue Market Share by Country (2021-2026) Table 98. Jinyu Corporation Information Table 99. Jinyu Description and Business Overview Table 100. Jinyu Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020) Table 101. Jinyu Brucellosis Vaccines Product Table 102. Jinyu Recent Development Table 103. Colorado Serum Corporation Information Table 104. Colorado Serum Description and Business Overview Table 105. Colorado Serum Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020) Table 106. Colorado Serum Brucellosis Vaccines Product Table 107. Colorado Serum Recent Development Table 108. Boehringer Ingelheim Corporation Information Table 109. Boehringer Ingelheim Description and Business Overview Table 110. Boehringer Ingelheim Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020) Table 111. Boehringer Ingelheim Brucellosis Vaccines Product Table 112. Boehringer Ingelheim Recent Development Table 113. Biogenesis-Bago Corporation Information Table 114. Biogenesis-Bago Description and Business Overview Table 115. Biogenesis-Bago Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020) Table 116. Biogenesis-Bago Brucellosis Vaccines Product Table 117. Biogenesis-Bago Recent Development Table 118. Vetal Company Corporation Information Table 119. Vetal Company Description and Business Overview Table 120. Vetal Company Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020) Table 121. Vetal Company Brucellosis Vaccines Product Table 122. Vetal Company Recent Development Table 123. CZ Veterinaria Corporation Information Table 124. CZ Veterinaria Description and Business Overview Table 125. CZ Veterinaria Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020) Table 126. CZ Veterinaria Brucellosis Vaccines Product Table 127. CZ Veterinaria Recent Development Table 128. SYVA Laboratorios Corporation Information Table 129. SYVA Laboratorios Description and Business Overview Table 130. SYVA Laboratorios Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020) Table 131. SYVA Laboratorios Brucellosis Vaccines Product Table 132. SYVA Laboratorios Recent Development Table 133. Indian Immunologicals Corporation Information Table 134. Indian Immunologicals Description and Business Overview Table 135. Indian Immunologicals Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020) Table 136. Indian Immunologicals Brucellosis Vaccines Product Table 137. Indian Immunologicals Recent Development Table 138. Qilu Corporation Information Table 139. Qilu Description and Business Overview Table 140. Qilu Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020) Table 141. Qilu Brucellosis Vaccines Product Table 142. Qilu Recent Development Table 143. Tecnovax Corporation Information Table 144. Tecnovax Description and Business Overview Table 145. Tecnovax Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020) Table 146. Tecnovax Brucellosis Vaccines Product Table 147. Tecnovax Recent Development Table 148. Hester Biosciences Corporation Information Table 149. Hester Biosciences Description and Business Overview Table 150. Hester Biosciences Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020) Table 151. Hester Biosciences Brucellosis Vaccines Product Table 152. Hester Biosciences Recent Development Table 153. Zoetis Corporation Information Table 154. Zoetis Description and Business Overview Table 155. Zoetis Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020) Table 156. Zoetis Brucellosis Vaccines Product Table 157. Zoetis Recent Development Table 158. Onderstepoort Biological Corporation Information Table 159. Onderstepoort Biological Description and Business Overview Table 160. Onderstepoort Biological Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020) Table 161. Onderstepoort Biological Brucellosis Vaccines Product Table 162. Onderstepoort Biological Recent Development Table 163. Instituto Rosenbusch Corporation Information Table 164. Instituto Rosenbusch Description and Business Overview Table 165. Instituto Rosenbusch Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020) Table 166. Instituto Rosenbusch Brucellosis Vaccines Product Table 167. Instituto Rosenbusch Recent Development Table 168. Ceva Sante Animale Corporation Information Table 169. Ceva Sante Animale Description and Business Overview Table 170. Ceva Sante Animale Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020) Table 171. Ceva Sante Animale Brucellosis Vaccines Product Table 172. Ceva Sante Animale Recent Development Table 173. Calier & Biologicos Laverlam Corporation Information Table 174. Calier & Biologicos Laverlam Description and Business Overview Table 175. Calier & Biologicos Laverlam Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020) Table 176. Calier & Biologicos Laverlam Brucellosis Vaccines Product Table 177. Calier & Biologicos Laverlam Recent Development Table 178. Biovet Corporation Information Table 179. Biovet Description and Business Overview Table 180. Biovet Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020) Table 181. Biovet Brucellosis Vaccines Product Table 182. Biovet Recent Development Table 183. Key Raw Materials Lists Table 184. Raw Materials Key Suppliers Lists Table 185. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 186. Key Challenges Table 187. Market Risks Table 188. Distributors List Table 189. Brucellosis Vaccines Downstream Customers Table 190. Research Programs/Design for This Report Table 191. Key Data Information from Secondary Sources Table 192. Key Data Information from Primary Sources List of Figures Figure 1. Brucellosis Vaccines Product Picture Figure 2. Global Brucellosis Vaccines Revenue (Million USD) Status and Outlook (2015-2026) Figure 3. Global Brucellosis Vaccines Sales (M Doses) Status and Outlook (2015-2026) Figure 4. Product Picture of S19 Vaccine Figure 5. Global S19 Vaccine Sales (M Doses) and Growth Rate (2015-2020) Figure 6. Product Picture of RB51 Vaccine Strain Figure 7. Global RB51 Vaccine Strain Sales (M Doses) and Growth Rate (2015-2020) Figure 8. Product Picture of Other Figure 9. Global Other Sales (M Doses) and Growth Rate (2015-2020) Figure 10. Global Brucellosis Vaccines Revenue and Growth Rate by Type (US$ Million) Figure 11. Global Brucellosis Vaccines Sales Market Share by Type (2015-2020) Figure 12. Global Brucellosis Vaccines Sales Market Share by Type in 2019 Figure 13. Global Brucellosis Vaccines Revenue Share by Type (2015-2020) Figure 14. Global Brucellosis Vaccines Revenue Market Share by Type in 2019 Figure 15. Global Brucellosis Vaccines Sales Market Share by Type (2021-2026) Figure 16. Global Brucellosis Vaccines Sales Market Share by Type In 2019 Figure 17. Global Brucellosis Vaccines Revenue Share by Type (2021-2026) Figure 18. Global Brucellosis Vaccines Revenue Market Share by Type In 2019 Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by Brucellosis Vaccines Sales in 2019 Figure 20. The 5 and 10 Largest Manufacturers in the World: Market Share by Brucellosis Vaccines Revenue in 2019 Figure 21. Brucellosis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 22. North America Brucellosis Vaccines Revenue (US$ Million) and Growth Rate (2015-2026) Figure 23. North America Brucellosis Vaccines Sales YoY Growth (2015-2026) (M Doses) Figure 24. Asia-Pacific Brucellosis Vaccines Revenue (US$ Million) and Growth Rate (2015-2026) Figure 25. Asia-Pacific Brucellosis Vaccines Sales YoY Growth (2015-2026) (M Doses) Figure 26. Europe Brucellosis Vaccines Revenue (US$ Million) and Growth Rate (2015-2026) Figure 27. Europe Brucellosis Vaccines Sales YoY Growth (2015-2026) (M Doses) Figure 28. Latin America Brucellosis Vaccines Revenue (US$ Million) and Growth Rate (2015-2026) Figure 29. Latin America Brucellosis Vaccines Sales YoY Growth (2015-2026) (M Doses) Figure 30. Middle East and Africa Brucellosis Vaccines Revenue (US$ Million) and Growth Rate (2015-2026) Figure 31. Middle East and Africa Brucellosis Vaccines Sales YoY Growth (2015-2026) (M Doses) Figure 32. Cattle Examples Figure 33. Sheep Examples Figure 34. Other Examples Figure 35. U.S. Brucellosis Vaccines Sales (M Doses) (2015-2026) Figure 36. U.S. Brucellosis Vaccines Revenue (US$ Million) (2015-2026) Figure 37. Canada Brucellosis Vaccines Sales (M Doses) (2015-2026) Figure 38. Canada Brucellosis Vaccines Revenue (US$ Million) (2015-2026) Figure 39. Germany Brucellosis Vaccines Sales (M Doses) (2015-2026) Figure 40. Germany Brucellosis Vaccines Revenue (US$ Million) (2015-2026) Figure 41. France Brucellosis Vaccines Sales (M Doses) (2015-2026) Figure 42. France Brucellosis Vaccines Revenue (US$ Million) (2015-2026) Figure 43. U.K. Brucellosis Vaccines Sales (M Doses) (2015-2026) Figure 44. U.K. Brucellosis Vaccines Revenue (US$ Million) (2015-2026) Figure 45. Italy Brucellosis Vaccines Sales (M Doses) (2015-2026) Figure 46. Italy Brucellosis Vaccines Revenue (US$ Million) (2015-2026) Figure 47. Russia Brucellosis Vaccines Sales (M Doses) (2015-2026) Figure 48. Russia Brucellosis Vaccines Revenue (US$ Million) (2015-2026) Figure 49. China Brucellosis Vaccines Sales (M Doses) (2015-2026) Figure 50. China Brucellosis Vaccines Revenue (US$ Million) (2015-2026) Figure 51. Japan Brucellosis Vaccines Sales (M Doses) (2015-2026) Figure 52. Japan Brucellosis Vaccines Revenue (US$ Million) (2015-2026) Figure 53. South Korea Brucellosis Vaccines Sales (M Doses) (2015-2026) Figure 54. South Korea Brucellosis Vaccines Revenue (US$ Million) (2015-2026) Figure 55. India Brucellosis Vaccines Sales (M Doses) (2015-2026) Figure 56. India Brucellosis Vaccines Revenue (US$ Million) (2015-2026) Figure 57. Australia Brucellosis Vaccines Sales (M Doses) (2015-2026) Figure 58. Australia Brucellosis Vaccines Revenue (US$ Million) (2015-2026) Figure 59. Taiwan Brucellosis Vaccines Sales (M Doses) (2015-2026) Figure 60. Taiwan Brucellosis Vaccines Revenue (US$ Million) (2015-2026) Figure 61. Indonesia Brucellosis Vaccines Sales (M Doses) (2015-2026) Figure 62. Indonesia Brucellosis Vaccines Revenue (US$ Million) (2015-2026) Figure 63. Thailand Brucellosis Vaccines Sales (M Doses) (2015-2026) Figure 64. Thailand Brucellosis Vaccines Revenue (US$ Million) (2015-2026) Figure 65. Malaysia Brucellosis Vaccines Sales (M Doses) (2015-2026) Figure 66. Malaysia Brucellosis Vaccines Revenue (US$ Million) (2015-2026) Figure 67. Philippines Brucellosis Vaccines Sales (M Doses) (2015-2026) Figure 68. Philippines Brucellosis Vaccines Revenue (US$ Million) (2015-2026) Figure 69. Vietnam Brucellosis Vaccines Sales (M Doses) (2015-2026) Figure 70. Vietnam Brucellosis Vaccines Revenue (US$ Million) (2015-2026) Figure 71. Mexico Brucellosis Vaccines Sales (M Doses) (2015-2026) Figure 72. Mexico Brucellosis Vaccines Revenue (US$ Million) (2015-2026) Figure 73. Brazil Brucellosis Vaccines Sales (M Doses) (2015-2026) Figure 74. Brazil Brucellosis Vaccines Revenue (US$ Million) (2015-2026) Figure 75. Argentina Brucellosis Vaccines Sales (M Doses) (2015-2026) Figure 76. Argentina Brucellosis Vaccines Revenue (US$ Million) (2015-2026) Figure 77. Turkey Brucellosis Vaccines Sales (M Doses) (2015-2026) Figure 78. Turkey Brucellosis Vaccines Revenue (US$ Million) (2015-2026) Figure 79. Saudi Arabia Brucellosis Vaccines Sales (M Doses) (2015-2026) Figure 80. Saudi Arabia Brucellosis Vaccines Revenue (US$ Million) (2015-2026) Figure 81. U.A.E Brucellosis Vaccines Sales (M Doses) (2015-2026) Figure 82. U.A.E Brucellosis Vaccines Revenue (US$ Million) (2015-2026) Figure 83. Jinyu Total Revenue (US$ Million): 2019 Compared with 2018 Figure 84. Colorado Serum Total Revenue (US$ Million): 2019 Compared with 2018 Figure 85. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018 Figure 86. Biogenesis-Bago Total Revenue (US$ Million): 2019 Compared with 2018 Figure 87. Vetal Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. CZ Veterinaria Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. SYVA Laboratorios Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Indian Immunologicals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Qilu Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Tecnovax Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Hester Biosciences Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Onderstepoort Biological Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Instituto Rosenbusch Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Ceva Sante Animale Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Calier & Biologicos Laverlam Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Biovet Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Key Raw Materials Price Figure 101. Brucellosis Vaccines Manufacturing Cost Structure Figure 102. Brucellosis Vaccines Industrial Chain Analysis Figure 103. Porter's Five Forces Analysis Figure 104. Channels of Distribution Figure 105. Distributors Profiles Figure 106. Bottom-up and Top-down Approaches for This Report Figure 107. Data Triangulation Figure 108. Key Executives Interviewed

Jinyu Colorado Serum Boehringer Ingelheim Biogenesis-Bago Vetal Company CZ Veterinaria SYVA Laboratorios Indian Immunologicals Qilu Tecnovax Hester Biosciences Zoetis Onderstepoort Biological Instituto Rosenbusch Ceva Sante Animale Calier & Biologicos Laverlam Biovet